News AbbVie signs $225m 'immunoneurology' deal to tackle Alzheime... Partnership will use novel approach to treating Alzheimer's.
News Biogen sees Spinraza slow down in Q3, bullish on Alzheimer's... Biogen has given investors a pleasant surprise with better-than-expected profits in Q3, but has puzzled analysts with a rapid slowdown for its new rare disease drug Spinraza.
News Non-drug approaches show promise against Alzheimer’s The NeuroEM 1000 prevented and reversed memory loss in mice.
Views & Analysis World Alzheimer's Day: latest research and a carer's perspec... On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.
News Could light emitting wearable device treat dementia? Device led to ‘significant clinical improvements' in Alzheimer's patients.
Views & Analysis Alzheimer’s research needs international approach New research initiatives aim to encourage pharma and academia to collaborate on dementia drug discovery, which is a high-risk field historically.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
